ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 330

The IMPACT of a Referral Algorithm for Axial Spondyloarthritis: Four Month Follow-up in Patient Reported Outcomes

Maha Jamal1, Amber Korver2, Martijn Kuijper3, Deirisa Lopes Barreto1, Frank van den Hoogen4, Cathelijne W. Y. Appels5, Anneke Spoorenberg6, Bart Koes7, Lonneke van Hoeven8, JMW Hazes9 and Angelique EAM Weel3, 1Maasstad Hospital, Rotterdam, Netherlands, 2Erasmuc Medical Center, Rotterdam, Netherlands, 3Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, 4Radboud Medical center, Nijmegen, Netherlands, 5Rheumatology, Amphia Hospital, Breda, Netherlands, 6Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 7Erasmuc Medical center, Rotterdam, Netherlands, 8Erasmus Medical center, Rotterdam, Netherlands, 9Rheumatology, Erasmus MC, Rotterdam, Netherlands

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: axial spondyloarthritis, chronic low back pain, disability and primary care, Referrals

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Measures and Measurement of Healthcare Quality Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: A substantial amount of patients with chronic low back pain (CLBP) have axial spondyloarthritis (axSpA), but early recognition of these patients is difficult for general practitioners (GPs). As a result, several referral strategies have been developed to help physicians identify patients at risk for axSpA within the large group of CLBP patients. Most referral strategies were developed in secondary care patients. The only referral strategy that was developed and validated in primary low back patients is the CaFaSpA strategy. After model development and validation it is important to perform an impact analysis before implementation in daily clinical practice. The purpose of this study is to assess the impact of using a referral strategy on patient outcomes in young primary care patients with CLBP at risk for axSPA.

Methods: A clustered randomized controlled trial was performed in a primary care setting (ClinicalTrials.gov Identifier: NCT01944163). Each cluster contained the general practices from a single primary care practice and their included patients. Clusters were randomized to either the intervention (use of CaFaSpA referral strategy) or the control group (usual care). Primary outcome was disability caused by CLBP, measured with the Roland Morris Disability Questionnaire (RMDQ) at baseline and 4 months. A linear mixed-effects model was used to analyze mean change in RMDQ score.

Results: In total 679 patients were included within 93 GP clusters. Sixty-four percent of our study population were female and mean age was 36 years. Median RMDQ score at baseline was 8 (IQR 4-12) in both groups. Compared to baseline, mean RMDQ score decreased by 0.74 points at 4 months (intervention) and by 0.46 points (control) (Figure 1). This decrease did not significantly differ between groups (p=0.50).

Conclusion: Although the CaFaSpA referral strategy can be used as a screening tool to identify axSpA patients but this strategy did not have an early impact on disability caused by CLBP.

Figure 1. Estimated mean RMDQ scores over time for the overall intervention and usual care group. Bars indicate 95% confidence intervals for the mean estimates.

 


Disclosure: M. Jamal, None; A. Korver, None; M. Kuijper, None; D. Lopes Barreto, None; F. van den Hoogen, None; C. W. Y. Appels, None; A. Spoorenberg, None; B. Koes, None; L. van Hoeven, None; J. Hazes, None; A. E. Weel, None.

To cite this abstract in AMA style:

Jamal M, Korver A, Kuijper M, Lopes Barreto D, van den Hoogen F, Appels CWY, Spoorenberg A, Koes B, van Hoeven L, Hazes J, Weel AE. The IMPACT of a Referral Algorithm for Axial Spondyloarthritis: Four Month Follow-up in Patient Reported Outcomes [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-impact-of-a-referral-algorithm-for-axial-spondyloarthritis-four-month-follow-up-in-patient-reported-outcomes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-a-referral-algorithm-for-axial-spondyloarthritis-four-month-follow-up-in-patient-reported-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology